Personal tools

MCL coexpression mm9:1801: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001016!3.43e-24!75;UBERON:0001017!9.76e-24!73;UBERON:0004121!6.88e-20!95;UBERON:0000924!6.88e-20!95;UBERON:0006601!6.88e-20!95;UBERON:0000073!3.89e-19!54;UBERON:0001049!6.89e-18!52;UBERON:0005068!6.89e-18!52;UBERON:0006241!6.89e-18!52;UBERON:0007135!6.89e-18!52;UBERON:0010314!2.10e-17!92;UBERON:0002346!4.86e-17!64;UBERON:0003075!4.86e-17!64;UBERON:0007284!4.86e-17!64;UBERON:0002020!1.50e-15!34;UBERON:0010371!9.57e-15!73;UBERON:0000955!1.17e-14!47;UBERON:0006238!1.17e-14!47;UBERON:0002616!3.58e-14!46;UBERON:0003080!7.82e-13!40;UBERON:0002780!2.14e-12!39;UBERON:0001890!2.14e-12!39;UBERON:0006240!2.14e-12!39;UBERON:0003528!2.52e-12!29;UBERON:0002791!2.52e-12!29;UBERON:0001893!2.52e-12!29;UBERON:0003056!4.02e-12!49;UBERON:0000025!1.05e-09!114;UBERON:0000468!8.35e-09!333;UBERON:0004111!8.52e-09!122;UBERON:0000956!4.57e-08!21;UBERON:0001869!4.57e-08!21;UBERON:0000203!4.57e-08!21;UBERON:0000479!1.72e-07!349;UBERON:0000922!4.54e-07!320
|ontology_enrichment_uberon=UBERON:0001016!3.43e-24!75;UBERON:0001017!9.76e-24!73;UBERON:0004121!6.88e-20!95;UBERON:0000924!6.88e-20!95;UBERON:0006601!6.88e-20!95;UBERON:0000073!3.89e-19!54;UBERON:0001049!6.89e-18!52;UBERON:0005068!6.89e-18!52;UBERON:0006241!6.89e-18!52;UBERON:0007135!6.89e-18!52;UBERON:0010314!2.10e-17!92;UBERON:0002346!4.86e-17!64;UBERON:0003075!4.86e-17!64;UBERON:0007284!4.86e-17!64;UBERON:0002020!1.50e-15!34;UBERON:0010371!9.57e-15!73;UBERON:0000955!1.17e-14!47;UBERON:0006238!1.17e-14!47;UBERON:0002616!3.58e-14!46;UBERON:0003080!7.82e-13!40;UBERON:0002780!2.14e-12!39;UBERON:0001890!2.14e-12!39;UBERON:0006240!2.14e-12!39;UBERON:0003528!2.52e-12!29;UBERON:0002791!2.52e-12!29;UBERON:0001893!2.52e-12!29;UBERON:0003056!4.02e-12!49;UBERON:0000025!1.05e-09!114;UBERON:0000468!8.35e-09!333;UBERON:0004111!8.52e-09!122;UBERON:0000956!4.57e-08!21;UBERON:0001869!4.57e-08!21;UBERON:0000203!4.57e-08!21;UBERON:0000479!1.72e-07!349;UBERON:0000922!4.54e-07!320
|tfbs_overrepresentation_for_novel_motifs=0.557864,0.612204,0.529553,0.603273,0.406364,0.618805,0.715644,0.812379,0.310789,1.22306,0.668936,0.702872,0.300533,0.728641,1.0876,0,0.930881,0.397593,0.775038,0.185796,0.489529,0.145201,0.727684,0.404661,0.537749,0.757752,0.274609,0.641282,1.15581,0.645258,0.626183,1.03545,0.395107,0.253145,1.08876,0.20704,1.7724,0.699032,0.360612,0.328675,0.401916,0.631725,0.830062,0.426986,0.227872,0.591277,0.847828,0.658142,0.746467,0.459555,0.912738,0.786094,0.627649,1.18062,1.19842,0.73621,0.469329,0.689304,0.26467,1.74061,1.01481,0.796017,0.323911,0.901018,0.747985,0.943088,1.33705,1.68977,1.00999,1.54147,0.509047,0.30684,1.45025,1.23259,2.03319,0.245132,0.253065,0.835925,0.997094,0.494135,0.308173,0.948899,0.794502,0.293164,2.51921,9.0509,0.0882907,0.227755,0.852952,1.85284,1.40768,1.11989,1.04863,0.412897,3.46853,0.3366,0.806207,1.05152,0.848095,0.20438,1.7727,1.03517,1.16282,0.913356,0.91226,0.631253,0.97421,0.653843,4.31326,1.23125,0.550229,1.16464,0.495367,0.674448,1.41481,0.399936,0.0998646,0.607321,0.932233,0.380707,1.23809,0.879184,0.759676,0.834976,1.46955,1.00091,0.724289,1.04166,1.33551,0.416189,1.14546,0.595426,1.3055,0.750642,1.43666,0.143464,0.566955,0.633235,1.3869,2.2222,1.82084,1.34183,0.772375,1.04623,0.905521,0.632211,0.851091,2.18247,0.569503,1.05179,2.65584,3.34092,1.18223,0.908552,0.749664,1.26545,0.787153,0.438007,0.555203,0.566652,1.39653,1.11392,1.00137,0.547782,0.90208,0.741834,0.383572,0.701187,0.745913
}}
}}

Revision as of 20:27, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr4:130348428..130348582,+p1@Sdc3
Mm9::chr4:130348609..130348635,+p5@Sdc3
Mm9::chr4:130348654..130348684,+p3@Sdc3
Mm9::chr4:130379228..130379250,+p@chr4:130379228..130379250
+
Mm9::chr4:140542796..140542851,+p1@Atp13a2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
nervous system3.43e-2475
central nervous system9.76e-2473
ectoderm-derived structure6.88e-2095
ectoderm6.88e-2095
presumptive ectoderm6.88e-2095
regional part of nervous system3.89e-1954
neural tube6.89e-1852
neural rod6.89e-1852
future spinal cord6.89e-1852
neural keel6.89e-1852
structure with developmental contribution from neural crest2.10e-1792
neurectoderm4.86e-1764
neural plate4.86e-1764
presumptive neural plate4.86e-1764
gray matter1.50e-1534
ecto-epithelium9.57e-1573
brain1.17e-1447
future brain1.17e-1447
regional part of brain3.58e-1446
anterior neural tube7.82e-1340
regional part of forebrain2.14e-1239
forebrain2.14e-1239
future forebrain2.14e-1239
brain grey matter2.52e-1229
regional part of telencephalon2.52e-1229
telencephalon2.52e-1229
pre-chordal neural plate4.02e-1249
tube1.05e-09114
multi-cellular organism8.35e-09333
anatomical conduit8.52e-09122
cerebral cortex4.57e-0821
cerebral hemisphere4.57e-0821
pallium4.57e-0821
tissue1.72e-07349
embryo4.54e-07320


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}